Acino will supply medicines for children with mental and behavioral disorders, schizophrenia, affective disorders, and hyperkinetic disorders
Acino Belarus won the prize with our #WorldHeartDay campaign, beating 80 participants including pharmaceutical manufacturers, distributors and pharmacy chains from 13 countries in the Eurasia region
This World Heart Day, September 29, and for the next year, Acino will support the World Heart Federation to raise awareness of cardiovascular disease (CVD) as the leading cause of death for patients around the world
As Quality Manager in the Third-Party Compliance team, my daily work involves supplier qualification for raw materials, services and audits. I also oversee audit management, quality reviews and risk assessments.
Eugene Zaika General Director of Acino in Ukraine and Regional Head of Acino in CIS, told pharma.net.ua that while the company’s ambitious plans have not yet been fully realized, they are still very relevant, especially at the moment.
At Supply Chain we support Acino’s business by managing inventories; securing raw materials; avoiding stock-out with a reliable end-to-end supply chain; and by maximizing spot business opportunities. I love the possibility to contribute to our collective ambition and success story in so many ways, and I am extremely proud of my team and the results they deliver day in day out no matter what.
USD 160,600 donated.
1,200 hospitals and 2,225 pharmacies assisted.
17,000 healthcare professionals and 5,000 pharmacists equipped.
We're in this together.
Monika leads Acino’s Bulk Production plants in Aesch and Liesberg, Switzerland. She works closely with our Contract Manufacturing team servicing B2B customers with best-in-class drug-delivery solutions for oral solid dosage forms.
We are currently all facing a time that we have never experienced before as individuals or as businesses; and are creating and adapting to new ways of living and working.
Acino and Takeda Pharmaceuticals announced today the completion of the acquisition for parts of Takeda’s primary care portfolio in selected countries in the Middle East, Africa, and Ukraine.